Associations between the combined expression of CD44/CD24/ALDH1 and the breast cancer molecular subtypes
| Luminal A | Luminal B | HER2-OE | Basal-like | Unclassified | ||
| CD44+CD24−/low<10% | ALDH1+ | 9 (3.1%) | 2 (4.9%) | 2 (6.1%) | 6 (8.8%) | 0 (0%) |
| ALDH1− | 159 (53.9%) | 22 (53.7%) | 22 (66.7%) | 10 (14.7%) | 18 (81.8%) | |
| CD44+CD24−/low≥10% | ALDH1+ | 6 (2.0%) | 3 (7.3%) | 2 (6.1%) | 11 (16.2%) | 0 (0%) |
| ALDH1− | 121 (41.0%) | 14 (34.1%) | 7 (21.2%) | 41 (60.3%) | 4 (18.2%) | |
| Total | 295 (100%) | 41 (100%) | 33 (100%) | 68 (100%) | 22 (100%) |
p≤0.0001.